Tumor organoids of patient R24, while displaying a basal‐like profile at baseline, showed a diverging marker expression after exposure to any of the tested chemotherapies, with EpCAM expressed in up to 100% of treated and analyzed tumor organoids (Figure S4, Table S9). The gene discussed is EPCAM; the disease is neoplasm.